The New York High-Risk Project: attention, anhedonia and social outcome

Schizophrenia Research
L R FreedmanL Erlenmeyer-Kimling

Abstract

In the New York High-Risk Project we have followed two samples of subjects (Sample A and Sample B) at risk for schizophrenic or affective disorders and low-risk controls from childhood to adulthood, in an attempt to identify early predictors of later psychopathology. We administered a large number of cognitive, psychometric and other types of measures to both samples as possible psychopathology predictors, including an index of attentional deviance assessed in childhood, the Physical Anhedonia Scale in adolescence, and three measures of social outcome in adulthood ('Suspicious Solitude', 'Social Insecurity', and 'Lack of Empathy'), derived from the Personality Disorders Examination. In the analysis of the combined samples, parental diagnostic group, gender, attentional deviance in childhood, and physical anhedonia in adolescence were used to predict three measures of social outcome in adulthood. While only physical anhedonia was directly related to all three social outcome measures, with the strongest relationship to Suspicious Solitude, attention deviance successfully predicted two of the three outcomes. Subjects at risk for affective disorder did not show increased levels of attention deviance, physical anhedonia, or social d...Continue Reading

References

Dec 1, 1979·Journal of Abnormal Psychology·M C HabermanR M McFall
Jan 1, 1978·Journal of Psychiatric Research·L Erlenmeyer-Kimling, B Cornblatt
Aug 1, 1976·Journal of Abnormal Psychology·L J ChapmanM L Raulin
Oct 1, 1992·Journal of Psychiatric Research·L Erlenmeyer-Kimling, B A Cornblatt
Feb 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·A FoersterR Murray
Jun 1, 1990·The British Journal of Psychiatry : the Journal of Mental Science·A S BellackK T Mueser
Jan 1, 1987·Schizophrenia Bulletin·R L Morrison, A S Bellack
Jan 1, 1987·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·A Raine
Jan 1, 1987·Schizophrenia Bulletin·P S Holzman
Jan 1, 1987·Schizophrenia Bulletin·L Erlenmeyer-Kimling, B Cornblatt
Nov 1, 1985·Journal of Abnormal Psychology·B A Cornblatt, L Erlenmeyer-Kimling
Jan 1, 1980·Schizophrenia Bulletin·L J ChapmanJ P Chapman
Jan 1, 1995·Schizophrenia Bulletin·D L PennD Reed
Aug 1, 1995·Journal of Abnormal Psychology·P M ChmielewskiG A Miller
Jan 1, 1993·Schizophrenia Bulletin·L Erlenmeyer-KimlingA West
Jan 1, 1993·Journal of Psychiatric Research·Elizabeth Squires-WheelerL Erlenmeyer-Kimling

❮ Previous
Next ❯

Citations

Mar 9, 2005·Archives of General Psychiatry·Rajendra A MoreyAysenil Belger
Mar 4, 2000·Psychiatry Research·D C GoodingT R Kwapil
Feb 20, 2003·Schizophrenia Research·Laura T NiemiJouko K Lönnqvist
Feb 16, 2005·Journal of Abnormal Psychology·Aprajita MohantyGregory A Miller
Oct 25, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Alexandra SolimanAlain Dagher
Dec 29, 2000·The Australian and New Zealand Journal of Psychiatry·P T MichieA Jablensky
Aug 12, 2005·Journal of Child and Adolescent Psychopharmacology·William S StoneUNKNOWN Consortium on the Genetics on Schizophrenia
Oct 14, 2005·Schizophrenia Bulletin·William P HoranJack J Blanchard
Jul 23, 2008·Schizophrenia Bulletin·Jouko Miettunen, Erika Jääskeläinen
Aug 1, 2008·Schizophrenia Bulletin·William P HoranMichael F Green
Jan 4, 2005·Psychotherapy and Psychosomatics·Inbar Nathans-BarelHenry Silver
Jul 27, 2006·Journal of Abnormal Psychology·Tasha M NienowThomas J Dinzeo
Jun 28, 2011·Schizophrenia Research·Alexandra SolimanAlain Dagher
Aug 19, 2010·Schizophrenia Research·Tracy BarbourVaibhav A Diwadkar
Apr 24, 2009·Journal of Clinical Psychology·Gwladys ReyStéphanie Dubal
Jun 2, 2005·Schizophrenia Research·Anne-Lise V Holahan, Gillian A O'Driscoll
Oct 3, 2006·Neuropsychologia·Joscelyn E FisherGregory A Miller
May 16, 2006·Psychiatry Research·Ingmar H A FrankenIlse M T Nijs
Dec 3, 2005·Schizophrenia Research·Christopher W SmithBarbara Cornblatt
May 25, 2010·Schizophrenia Research·Nicoletta M J van VeelenMargriet M Sitskoorn
Jul 2, 2008·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Elisa Kijner GuttFrancisco Lotufo-Neto
Jan 26, 2011·Development and Psychopathology·María José RodrigoMaría Antonieta Bobes
Oct 3, 2006·The British Journal of Psychiatry : the Journal of Mental Science·Stephen J GlattMing T Tsuang
Nov 7, 2000·Reviews in the Neurosciences·J Lehmann, J Feldon
Sep 6, 2000·The Journal of Nervous and Mental Disease·C A Pope, T R Kwapil
May 17, 2000·American Journal of Medical Genetics·R FreedmanS Leonard
Nov 11, 2009·The Spanish Journal of Psychology·Eduardo Fonseca-PedreroJosé Muñiz
Jul 13, 2017·Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Österreichischer Nervenärzte und Psychiater·Hans-Peter Kapfhammer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.